Canopy Growth Stock (NASDAQ:CGC)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$3.83

52W Range

$2.75 - $14.92

50D Avg

$4.54

200D Avg

$6.21

Market Cap

$480.67M

Avg Vol (3M)

$5.06M

Beta

1.78

Div Yield

-

CGC Company Profile


Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

Show More

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

CA

Employees

1,029

IPO Date

Apr 07, 2014

Website

CGC Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceMar 24Mar 23Mar 22
Other Revenue$10.19M$16.36M-
International And Other Revenue--$36.11M
Canadian Recreational Cannabis Net Revenue--$205.30M
Global Cannabis Net Revenue--$337.22M
Canadian Medical Cannabis Net Revenue--$52.61M
Canadian Cannabis Net Revenue--$257.91M
Consumer Products And Other--$183.11M

Fiscal year ends in Mar 24 | Currency in USD

CGC Financial Summary


Mar 24Mar 23Mar 22
Revenue$297.15M$402.90M$520.33M
Operating Income$-228.71M$1.67B$-1.08B
Net Income$-657.27M$-3.31B$-320.49M
EBITDA$-88.15M$1.75B$-229.58M
Basic EPS$-8.79$-7.14$-0.82
Diluted EPS$-8.79$-7.14$-0.82

Fiscal year ends in Mar 24 | Currency in USD

Latest Earnings Call Transcripts


Q2 25Nov 08, 24 | 12:17 PM
Q1 25Aug 09, 24 | 2:05 PM
Q4 24May 30, 24 | 1:03 PM